Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

Related Citations for PubMed (Select 23608108)


Synthesis and characterization of 123I-CMICE-013: a potential SPECT myocardial perfusion imaging agent.

Wei L, Bensimon C, Lockwood J, Yan X, Fernando P, Wells RG, Duan Y, Chen YX, Redshaw JR, Covitz PA, Ruddy TD.

Bioorg Med Chem. 2013 Jun 1;21(11):2903-11. doi: 10.1016/j.bmc.2013.03.080. Epub 2013 Apr 6.


Characterization of the four isomers of (123)I-CMICE-013: a potential SPECT myocardial perfusion imaging agent.

Wei L, Bensimon C, Yan X, Lockwood J, Gan W, Wells RG, Duan Y, Fernando P, Gottlieb B, Mullett W, Ruddy TD.

Bioorg Med Chem. 2014 Apr 1;22(7):2033-44. doi: 10.1016/j.bmc.2014.02.052. Epub 2014 Mar 4.


Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.

Mou T, Zhao Z, Fang W, Peng C, Guo F, Liu B, Ma Y, Zhang X.

J Nucl Med. 2012 Mar;53(3):472-9. doi: 10.2967/jnumed.111.088096. Epub 2012 Feb 2.


Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.

Goethals LR, Santos I, Caveliers V, Paulo A, De Geeter F, Lurdes PG, Fernandes C, Lahoutte T.

Contrast Media Mol Imaging. 2011 Jul-Aug;6(4):178-88. doi: 10.1002/cmmi.413. Epub 2010 Dec 29.


Biodistribution and radiodosimetry of a novel myocardial perfusion tracer 123I-CMICE-013 in healthy rats.

Duan Y, Lockwood J, Wei L, Hunter C, Soueidan K, Bensimon C, Fernando P, Wells RG, Ruddy TD.

EJNMMI Res. 2014 Mar 13;4(1):16. doi: 10.1186/2191-219X-4-16.


Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.

Cona MM, Feng Y, Li Y, Chen F, Vunckx K, Zhou L, Van Slambrouck K, Rezaei A, Gheysens O, Nuyts J, Verbruggen A, Oyen R, Ni Y.

J Cardiovasc Pharmacol. 2013 Sep;62(3):304-11. doi: 10.1097/FJC.0b013e31829b2c6b.


Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.

Boschi A, Uccelli L, Bolzati C, Duatti A, Sabba N, Moretti E, Di Domenico G, Zavattini G, Refosco F, Giganti M.

J Nucl Med. 2003 May;44(5):806-14.


Kinetic characterization of a novel cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, for myocardial perfusion imaging.

Liu Z, Chen L, Liu S, Barber C, Stevenson GD, Furenlid LR, Barrett HH, Woolfenden JM.

J Nucl Cardiol. 2010 Oct;17(5):858-67. doi: 10.1007/s12350-010-9262-y. Epub 2010 Jul 29.


Simultaneous assessment of Tc-99m-sestamibi and I-123-BMIPP myocardial distribution in patients with myocardial infarction: evaluation of left ventricular function with ECG-gated myocardial SPECT.

Kumita S, Cho K, Nakajo H, Toba M, Kijima T, Mizumura S, Kumazaki T, Sano J, Munakata K, Kishida H, Takano T.

Ann Nucl Med. 2000 Dec;14(6):453-9.


99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.

Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK.

J Nucl Med. 2004 Dec;45(12):2095-101.


Correlation between severity of coronary artery stenosis and perfusion defect assessed by SPECT myocardial perfusion imaging.

Zaman MM, Haque SS, Siddique MA, Banerjee S, Ahmed CM, Sharma AK, Rahman MF, Haque MH, Joarder AI, Sultan AU, Fatema K.

Mymensingh Med J. 2010 Oct;19(4):608-13.


Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.

Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, Salvadori PA, Pisani P, L'abbate A.

J Nucl Cardiol. 2004 Mar-Apr;11(2):142-51.


Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.

Mekkaoui C, Jadbabaie F, Dione DP, Meoli DF, Purushothaman K, Belardinelli L, Sinusas AJ.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1198-208. doi: 10.1016/j.jcmg.2009.06.013.


The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.

Yu M, Nekolla SG, Schwaiger M, Robinson SP.

Semin Nucl Med. 2011 Jul;41(4):305-13. doi: 10.1053/j.semnuclmed.2011.02.004. Review.


Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.


Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.

Fonge H, Vunckx K, Wang H, Feng Y, Mortelmans L, Nuyts J, Bormans G, Verbruggen A, Ni Y.

Eur Heart J. 2008 Jan;29(2):260-9. Epub 2007 Dec 20.


In vivo detection of stem cells grafted in infarcted rat myocardium.

Zhou R, Thomas DH, Qiao H, Bal HS, Choi SR, Alavi A, Ferrari VA, Kung HF, Acton PD.

J Nucl Med. 2005 May;46(5):816-22.


BMS-747158-02: a novel PET myocardial perfusion imaging agent.

Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, Radeke H, Azure M, Purohit A, Casebier DS, Robinson SP.

J Nucl Cardiol. 2007 Nov-Dec;14(6):789-98. Epub 2007 Oct 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk